Search and Browse
Download
Enter Data
Your request to link to UniProt for Programmed cell death 1 ligand 1
| Target | Enzymatic | Kinetic | ITC | Articles | Downloads | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary ID | UniProt Recommended Name | Secondary IDs | BindingDB Name | Ki | IC50 | Kd | EC50 | koff | kon | Lig | Prot | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-239] | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 | 0 | 1626 | 31 | 1 | 0 | 0 | 0 | 23 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [18-239,H172E]/protein 1 [25-167,N33K],P01857[99-330,C104S,C109S,C112S,L118I,P121S] | 0 | 33 | 0 | 0 | 0 | 0 | 0 | 2 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/2 | 0 | 432 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand/protein 1 | 0 | 689 | 0 | 34 | 0 | 0 | 0 | 29 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1/protein 1 [25-167] | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 1 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | Programmed cell death 1 ligand 1 [19-238]/protein 1 [25-167] | 0 | 2260 | 0 | 381 | 0 | 0 | 0 | 10 | ||
| Q9NZQ7 | Programmed cell death 1 ligand 1 | B2RBA2 B4DU27 Q14CJ2 Q2V8D5 Q66RK1 Q6WEX4 Q9NUZ5 | ... | 0 | 5074 | 31 | 416 | 0 | 0 | 0 | 59 | 2D 3D TSV | |